酸用于单基性:文献综述
Amelia Stone1, Jacqueline Burré2, Natalie Wayland1
1Division of Pediatric Neurology, Weill Cornell Medicine, 1320 York Avenue, New York, NY 10021, USA.
Epilepsy research
|July 9, 2025
概括
4-甲酸 (PBA) 在治疗由单基因突变引起的遗传方面表现有前途. 本综述探讨了PBA的使用情况.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 单遗传性源于单基因缺陷,影响500多个基因,占病例的40%左右.
- 这些遗传性有不同的表型,通常包括发育和运动迟缓,并且经常对传统治疗有抗性.
- 现有的抗药物往往是无效的,突出需要新的治疗策略.
研究的目的:
- 审查各种单遗传性的临床概况.
- 探索这些特定遗传疾病中活动的致病性.
- 评估4-甲酸 (PBA) 对基因相关综合征的潜在治疗益处.
主要方法:
- 对临床和临床前数据的文献综述.
- 对4-基酸盐 (PBA) 拟议的作用机制的分析.
- 专注于具有潜在PBA疗效的基因相关综合征.
主要成果:
- 临床前研究表明,PBA在STXBP1,SLC6A1,SCN1A (德拉维特综合征) 和LGI1变体等遗传性中表现出抗发作作用.
- 临床证据表明PBA在SYNGAP1相关的中可能具有治疗作用.
- PBA的机制可能涉及解决潜在遗传缺陷的功能影响.
结论:
- 4-甲酸 (PBA) 显示出作为针对特定单遗传性的向治疗的潜力.
- 对PBA的疗效和机制进行进一步的研究对于耐药性遗传性是有必要的.
- PBA可能为治疗选择有限的患者提供一种新的治疗途径.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
665
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
665
Epilepsy and Seizures: Overview
291
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
291
Antiepileptic Drugs: Glutamate Antagonists
523
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
523
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
456
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
456
Antiepileptic Drugs: Sodium Channel Blockers
911
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
911
Antiepileptic Drugs: Potassium Channel Activators
283
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
283


